NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

TD Cowen Boosts TransMedics Price Target to $120 on Strong Transplant Growth

Accelerating U.S. heart, liver & lung transplants plus strong flight data signal major growth ahead.

TD Cowen Boosts TransMedics Price Target to $120 on Strong Transplant Growth
Credit: PRNewswire/TransMedics
Already have an account? Sign in.
07/01/2026 · 3:38 PM
TMDX
/ Don’t stop at just one post.

Related↓

Why TransMedics Stock Fell — and Why Analysts Aren’t Worried
01/21/2026 · 3:34 PM

Why TransMedics Stock Fell — and Why Analysts Aren’t Worried

TransMedics shares dropped after FDA clearance of a rival liver perfusion system, but TD Cowen says the selloff is overdone and sees no real competitive threat.

/ Subscriber only
/ Read more

Feed↓

Morgan Stanley Upgrades Grindr to Overweight, Sees 25% Upside on AI and Telehealth Push
07/01/2026 · 4:01 PM

Morgan Stanley Upgrades Grindr to Overweight, Sees 25% Upside on AI and Telehealth Push

New Edge AI tier and Woodwork telehealth expected to drive strong revenue growth.

/ Subscriber only
Short Seller Culper Attacks Tarsus Pharmaceuticals Over XDEMVY Market Size
07/01/2026 · 1:21 PM

Short Seller Culper Attacks Tarsus Pharmaceuticals Over XDEMVY Market Size

Culper Research argues Tarsus is significantly overvalued, disputing the addressable market for its Demodex blepharitis drug XDEMVY.

/ Subscriber only
Guardant Health Shares Surge as UnitedHealthcare Covers Shield Blood Test
Featured/ 07/01/2026 · 12:14 PM

Guardant Health Shares Surge as UnitedHealthcare Covers Shield Blood Test

UnitedHealthcare will begin reimbursing Guardant Health’s Shield colorectal cancer blood test from August 1, driving strong investor reaction and broader commercial access.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe